The presence of adipose tissue inflammation in T2DM has increased interest in anti-inflammatory treatments for T2DM and related vascular, neurological, and immunological complications
The use of a dulaglutide, a GLP-1, led to a 14 percent reduction in diagnosis of cognitive dysfunction reported in patients with type 2 diabetes in the REWIND trial [funded by Eli Lilly]
Your Patient Care Coordinator is your dedicated point of contact, available to assist with appointment scheduling, questions, phone calls, and even secure text messaging
, Wattchow, D
Future Considerations GLP-1 therapies should be used as an adjunct to lifestyle modifications, and healthcare professionals should be aware of the available GLP-1 therapies, their mechanisms of action, dosing regimens, and safety profiles